The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples